LEADER 02066nam  2200529 a 450 
001 9910465547903321
005 20200520144314.0
010   $a1-61324-372-3
035   $a(CKB)2560000000071292
035   $a(EBL)3019437
035   $a(SSID)ssj0000469503
035   $a(PQKBManifestationID)12124210
035   $a(PQKBTitleCode)TC0000469503
035   $a(PQKBWorkID)10510176
035   $a(PQKB)11590249
035   $a(MiAaPQ)EBC3019437
035   $a(Au-PeEL)EBL3019437
035   $a(CaPaEBR)ebr10671002
035   $a(OCoLC)705945748
035   $a(EXLCZ)992560000000071292
100   $a20090630d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aGeneric drugs$b[electronic resource] $eneeds and issues /$fRyan S. Blanton, editor
210   $aNew York $cNova Science Publishers$d2009
215   $a1 online resource (169 p.)
225 1 $aHealth care issues, costs and access
300   $aDescription based upon print version of record.
311   $a1-60692-843-0 
320   $aIncludes bibliographical references and index.
327   $aAuthorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office.
410  0$aHealth care issues, costs, and access.
606   $aGeneric drugs$zUnited States
608   $aElectronic books.
615  0$aGeneric drugs
676   $a338.4/76151
701   $aBlanton$b Ryan S$0914381
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910465547903321
996   $aGeneric drugs$92048549
997   $aUNINA